NCT Number: NCT01684852
Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution
This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Dr. Peter Otto, Bad Liebenwerda, Germany
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male or female person aged 18 years
- Demonstrated mild to moderate keratoconjunctivitis sicca ( "dry eye")
- Acute symptoms of dry eye: DEWS 1-3
- tear break-up time TBUT <10s
- agreement to abide by the routinely provided doctor's appointment for follow-up (reflected in the planned visits of observation plan resist)
Exclusion criteria
- inflammation of the anterior segment or trauma
- Contact lens wearers
- Any disease that can, in the opinion of the treating physician to affect the outcome of the study.
- Patients with known intolerance to one of the substances used
- Surgical procedures to the eyes in the last 6 weeks before inclusion in the trial
- patients with addictive disorders or substance abuse fallow in the past 12 months, as well as persons incapable of giving consent
Treatment and study plan
Primary outcomes
-
Tear Break Up Time
Time frame: V1 and V2
Sponsors and collaborators
Lead sponsor
Bitop AG
Industry
Registry information
Official study title
Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution (BAT04) Compared to HA Eye Drops in the Treatment of Dry Eye Disease
Important dates
- Study start
- 2012
- Primary completion
- 2012
- Study completion
- 2012
- First posted
- Sep 13, 2012
- Registry last updated
- Jan 29, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome
NCT05481450
Dry Eye, Dry Eye Syndromes
Lutz, Florida, United States
View Trial DetailsPreoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction
NCT06483750
Cataract Senile, Dry Eye Disease
Washington D.C., District of Columbia, United States
View Trial DetailsTolerability Comparison of Flarex to Lotemax SM
NCT07588074
Conjunctival Diseases, Conjunctivitis
Baton Rouge, Louisiana, United States
View Trial DetailsAssessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs
NCT04730336
Dry Eye, Dry Eye Syndromes
Solihull, United Kingdom
View Trial Details